Abstract

Copper-containing agents are promising antitumor pharmaceuticals due to the ability of the metal ion to react with biomolecules. In the current study, we demonstrate that inorganic Cu2+ in the form of oxide nanoparticles (NPs) or salts, as well as Cu ions in the context of organic complexes (oxidation states +1, +1.5 and +2), acquire significant cytotoxic potency (2–3 orders of magnitude determined by IC50 values) in combinations with N-acetylcysteine (NAC), cysteine, or ascorbate. In contrast, other divalent cations (Zn, Fe, Mo, and Co) evoked no cytotoxicity with these combinations. CuO NPs (0.1–1 µg/mL) together with 1 mM NAC triggered the formation of reactive oxygen species (ROS) within 2–6 h concomitantly with perturbation of the plasma membrane and caspase-independent cell death. Furthermore, NAC potently sensitized HCT116 colon carcinoma cells to Cu–organic complexes in which the metal ion coordinated with 5-(2-pyridylmethylene)-2-methylthio-imidazol-4-one or was present in the coordination sphere of the porphyrin macrocycle. The sensitization effect was detectable in a panel of mammalian tumor cell lines including the sublines with the determinants of chemotherapeutic drug resistance. The components of the combination were non-toxic if added separately. Electrochemical studies revealed that Cu cations underwent a stepwise reduction in the presence of NAC or ascorbate. This mechanism explains differential efficacy of individual Cu–organic compounds in cell sensitization depending on the availability of Cu ions for reduction. In the presence of oxygen, Cu+1 complexes can generate a superoxide anion in a Fenton-like reaction Cu+1L + O2 → O2−. + Cu+2L, where L is the organic ligand. Studies on artificial lipid membranes showed that NAC interacted with negatively charged phospholipids, an effect that can facilitate the penetration of CuO NPs across the membranes. Thus, electrochemical modification of Cu ions and subsequent ROS generation, as well as direct interaction with membranes, represent the mechanisms of irreversible membrane damage and cell death in response to metal reduction in inorganic and organic Cu-containing compounds.

Highlights

  • Biocompatible agents containing copper in an inorganic form or in the context of metal–organic complexes are widely used in a variety of applications, largely as antibacterial and antifungal drugs, as well as in tumor treatment [1,2,3,4,5]

  • Given that the cytotoxicity of copper-containing compounds has been mechanistically attributed to reactive oxygen species (ROS) [23], we used non-toxic concentrations of NAC to modulate the efficacy of CuO NPs

  • These results indicated at a 10-fold excess, S11)). These results indicated that that at a 10-fold excess, all of all of the copper was in an ionic form, and these ions were coordinated by the products the copper was in an ionic form, and these ions were coordinated by the products genergenerated inprocess the process of reduction

Read more

Summary

Introduction

Biocompatible agents containing copper in an inorganic form or in the context of metal–organic complexes are widely used in a variety of applications, largely as antibacterial and antifungal drugs, as well as in tumor treatment [1,2,3,4,5]. Copper’s unique sensitivity to the electrochemical status makes it advantageous in situations where the biological effects are mechanistically dependent on reactive oxygen species (ROS) [15,16,17,18,19]. These studies have highlighted the opportunity of using Cu-containing compounds alone or in combinations with conventional and novel agents. Zheng et al [20] showed that the combination of CuCl2 and the antioxidant

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call